NasdaqCM - Delayed Quote USD
Jaguar Health, Inc. (JAGX)
6.60
-1.17
(-15.06%)
At close: May 13 at 4:00:02 PM EDT
6.86
+0.26
+(3.94%)
After hours: May 13 at 7:57:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,384
-29,384
-33,104
-34,970
-15,278
Investing Cash Flow
-231
-231
-1,675
-6
-7
Financing Cash Flow
31,202
31,202
23,181
43,937
19,492
End Cash Position
8,002
8,002
5,469
17,051
8,090
Interest Paid Supplemental Data
14
14
23
28
757
Capital Expenditure
-231
-231
-1,675
-6
-7
Issuance of Capital Stock
31,910
31,910
20,462
33,578
1,949
Issuance of Debt
0
--
3,975
10,975
12,300
Repayment of Debt
-100
-100
-100
-1,922
-6,613
Free Cash Flow
-29,615
-29,615
-34,779
-34,976
-15,285
12/31/2020 - 5/12/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IBIO iBio, Inc.
0.8000
+1.09%
TNXP Tonix Pharmaceuticals Holding Corp.
20.18
+5.16%
OCGN Ocugen, Inc.
0.7025
+0.36%
ENSC Ensysce Biosciences, Inc.
2.0700
-5.48%
VXRT Vaxart, Inc.
0.4155
+2.59%
SPRC SciSparc Ltd.
0.3390
-5.02%
ATOS Atossa Therapeutics, Inc.
0.8900
+6.34%
BDRX Biodexa Pharmaceuticals Plc
1.2900
+4.88%
PLRZ Polyrizon Ltd.
0.0285
-91.86%
ADTX Aditxt, Inc.
1.6300
-8.94%